U.S. Market to Reach USD 6.37 Billion and Europe USD 7.11 Billion by 2035 as Premium IOL, MIGS, and Drug-Delivery Implant Adoption Expands.

Austin, United States, Aug. 26, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Ocular Implants Market was valued at USD 16.68 Billion in 2025 and is expected to reach USD 29.62 Billion by 2035, growing at a CAGR of 5.89% from 2026 to 2035. The market is estimated at USD 17.67 Billion in 2026. Growth is supported by rising prevalence of cataracts, glaucoma, age-related macular degeneration, and other vision disorders, along with increasing adoption of premium intraocular lenses, glaucoma implants, and minimally invasive ophthalmic procedures.

Advances in multifocal, toric, and extended-depth-of-focus intraocular lenses are increasing treatment options for cataract patients. MIGS devices are also gaining adoption, while sustained-release ocular drug-delivery implants are creating new treatment approaches for chronic retinal and glaucoma conditions.


Download the Ocular Implants Market Sample Report: https://www.snsinsider.com/sample-request/6536

Key Market Highlights

  • Market size, 2025: USD 16.68 Billion
  • Market size, 2026E: USD 17.67 Billion
  • Market forecast, 2035: USD 29.62 Billion
  • CAGR: 5.89% from 2026 to 2035
  • Largest region: North America
  • Fastest-growing region: Asia Pacific
  • Largest product segment: Glaucoma implants, over 27.3% share in 2025
  • Largest application: Glaucoma surgery, approximately 31.2% share in 2025
  • Largest end-use: Hospitals, over 40.2% share in 2025

Market Relevance

Ocular implants are increasingly used in cataract correction, glaucoma treatment, retinal disease management, refractive correction, and ocular reconstruction. Rising procedure volumes and an aging global population are increasing demand for both conventional and advanced implant technologies.

Premium IOLs, MIGS devices, sustained-release drug-delivery systems, and phakic IOLs are expanding the range of treatment options available to ophthalmologists and patients. Growing use of ambulatory surgical centers is also supporting higher ophthalmic procedure capacity.

Market Overview

The Ocular Implants Market includes intraocular lenses, glaucoma implants, corneal implants, orbital implants, ocular prostheses, and implantable drug-delivery systems.

Technology development is focused on improving visual outcomes, reducing dependence on spectacles, lowering intraocular pressure, and reducing the treatment burden associated with repeated ocular injections. AI-assisted surgical guidance and robotic ophthalmic platforms are also supporting more accurate implant positioning.

Strategic Market Outlook

Growth opportunities are increasing across premium IOLs, minimally invasive glaucoma surgery, and sustained-release ocular drug delivery. Emerging markets are also expanding ophthalmic surgical capacity as healthcare investment and access to cataract and glaucoma treatment improve.

However, high surgical costs and limited access to specialized ophthalmologists remain important restraints. Premium IOLs and advanced glaucoma implants may require significant out-of-pocket spending, particularly in markets where reimbursement remains limited.

Regional Analysis

North America held the largest share of the global Ocular Implants Market in 2025, supported by high ophthalmic procedure volumes, advanced healthcare infrastructure, reimbursement availability, and rapid adoption of premium IOL and MIGS technologies. The United States accounted for approximately 82.5% of North American revenue.

The U.S. Ocular Implants Market was valued at approximately USD 3.99 Billion in 2025 and is expected to reach USD 6.37 Billion by 2035, growing at a CAGR of approximately 4.78%.

Europe was valued at USD 4.17 Billion in 2025 and is expected to reach USD 7.11 Billion by 2035, growing at a CAGR of 5.48% from 2026 to 2035. Germany accounted for approximately 24.6% of European revenue in 2025, supported by established ophthalmic care infrastructure and medical-device manufacturing capabilities.

Asia Pacific is expected to be the fastest-growing region during the forecast period. China accounted for approximately 40.6% of regional revenue in 2025, supported by expanding ophthalmology infrastructure and increasing availability of cost-competitive ocular implants. India, China, and Indonesia are also increasing surgical capacity and access to cataract treatment.

In other regions, the UAE accounted for approximately 22.8% of Middle East & Africa revenue, while Brazil represented approximately 43.8% of Latin American revenue in 2025.

Buy the Ocular Implants Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/6536

Segment Analysis

By Product: Glaucoma implants held more than 27.3% market share in 2025, supported by rising glaucoma prevalence and growing adoption of MIGS procedures. Intraocular lenses are expected to grow fastest, driven by increasing cataract surgery volumes and demand for multifocal, toric, and EDOF lenses.

By Application: Glaucoma surgery accounted for approximately 31.2% of market revenue in 2025, supported by increasing use of drainage implants, stents, and micro-implants. Age-related macular degeneration is expected to grow fastest, supported by increasing interest in sustained-release anti-VEGF and retinal implant technologies.

By End Use: Hospitals dominated with more than 40.2% market share in 2025, supported by established ophthalmic surgical infrastructure and high procedure volumes. Specialty eye institutes are expected to grow fastest as dedicated ophthalmology networks expand cataract, glaucoma, and retinal treatment capacity.

Key Industry Trends

  • Increasing adoption of premium multifocal, toric, and EDOF IOLs
  • Growing use of MIGS implants in glaucoma treatment
  • Expansion of sustained-release intraocular drug-delivery implants
  • Rising use of phakic IOLs for refractive correction
  • Increasing use of AI-assisted ophthalmic surgery
  • Expansion of ambulatory surgical centers for cataract procedures
  • Growing ophthalmic surgical capacity in emerging markets

Competitive Landscape

The Ocular Implants Market is characterized by competition across intraocular lenses, glaucoma implants, drug-delivery systems, corneal implants, and other ophthalmic devices. Companies are focusing on premium IOL technologies, minimally invasive glaucoma devices, sustained-release treatment platforms, and expanded ophthalmic product portfolios.

Major key players include Alcon, Inc., Bausch + Lomb, Carl Zeiss AG, Johnson & Johnson Services, Inc., STAAR Surgical, MORCHER GmbH, Glaukos Corporation, HumanOptics AG, Rayner Intraocular Lenses Ltd., Ophtec BV, Beaver-Visitec International, Santen Pharmaceutical Co., Ltd., Nidek Co., Ltd., Iridex Corporation, EyePoint Pharmaceuticals, Inc., AbbVie Inc., Alimera Sciences, CorneaGen, Contamac Ltd., and SOLEKO S.p.A.

Explore the Complete Ocular Implants Market Report: https://www.snsinsider.com/reports/ocular-implants-market-6536

CONTACT: About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315-961-9094 (US)
Email: info@snsinsider.com